Citations

Clear

3942 citation(s) found for "To, Van".

Pathogenesis and Treatment of Dupuytren Disease
Riester, Scott M. , Wijnen, André J. van , Rizzo, Marco , Riester, Scott, Kakar, Sanjeev , van Wijnen, Andre J

Mayo Clinic

JBJS Reviews | April 9, 2014 | Volume: 2 | Issue: 4 | Pages: No page available

10.2106/jbjs.rvw.m.00072 | PMID 27490872 Get It

A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories
Akimoto, Chizuru, Volk, Alexander E. , Blitterswijk, Marka van , Broeck, Marleen Van den , Leblond, Claire S. , Lumbroso, Serge , Camu, William, Neitzel, Birgit, Onodera, Osamu , Pinto, Susana , Weber, Markus , Smith, Bradley , Proven, Melanie , Talbot, Kevin , Keagle, Pamela , Chesi, Alessandra , Ratti, Antonia , Zee, Julie van der , Alstermark, Helena, Birve, Anna, Calini, Daniela, Nordin, Angelica , Tradowsky, Daniela C, Just, Walter, Daoud, Hussein , Angerbauer, Sabrina, DeJesus‐Hernandez, Mariely, Konno, Takuya , Lloyd-Jani, Anjali, Mouzat, Kévin , Landers, John E. , Veldink, Jan H. , Silani, Vincenzo , Gitler, Aaron D. , Shaw, Christopher E. , Berg, Leonard H. van den , Broeckhoven, Christine Van , Rademakers, Rosa , Kubisch, Christian , van Blitterswijk, Marka, DeJesus-Hernandez, Mariely, Rheenen, Wouter van , Tradowsky, Daniela C., Carvalho, Mamede A. de , Rouleau, Guy Armand , Andersen, Peter Munch , van Blitterswijk, Marka , Silani, Vincenzo , Gitler, Aaron D , Veldink, Jan H , Konno, Takuya , Onodera, Osamu , Talbot, Kevin , Volk, Alexander E

Mayo Clinic

Journal of Medical Genetics | April 5, 2014 | Volume: 51 | Issue: 6 | Pages: 419-424

10.1136/jmedgenet-2014-102360 | PMID 24706941 Get It

Background The GGGGCC-repeat expansion in C9orf72 is the most frequent mutation found in patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Most of the studies on C9orf72 have relied on repeat-primed PCR (RP-PCR) methods for detection of the expansions. To investigate the inherent limitations of this technique, we compared methods and results of 14 laboratories. Methods The 14 laboratories genotyped DNA from 78 individuals (diagnosed with ALS or FTD) in a blinded fashion. Eleven laboratories used a combination of amplicon-length analysis and RP-PCR, whereas three laboratories used RP-PCR alone; Southern blotting techniques were used as a reference. Results Using PCR-based techniques, 5 of the 14 laboratories got results in full accordance with the Southern blotting results. Only 50 of the 78 DNA samples got the same genotype result in all 14 laboratories. There was a high degree of false positive and false negative results, and at least one sample could not be genotyped at all in 9 of the 14 laboratories. The mean sensitivity of a combination of amplicon-length analysis and RP-PCR was 95.0% (73.9–100%), and the mean specificity was 98.0% (87.5–100%). Overall, a sensitivity and specificity of more than 95% was observed in only seven laboratories. Conclusions Because of the wide range seen in genotyping results, we recommend using a combination of amplicon-length analysis and RP-PCR as a minimum in a research setting. We propose that Southern blotting techniques should be the gold standard, and be made obligatory in a clinical diagnostic setting.
Craniotomy for anterior cranial fossa meningiomas: historical overview
Morales-Valero, Saul F., Loumiotis, Ioannis , Gompel, Jamie J. Van , Lanzino, Giuseppe

Mayo Clinic

Neurosurgical Focus | April 1, 2014 | Volume: 36 | Issue: 4 | Pages: E14

10.3171/2014.1.focus13569 | PMID 24684326 Get It

The surgical treatment of meningiomas located at the base of the anterior cranial fossa is often challenging, and the evolution of the surgical strategy to resect these tumors parallels the development of craniotomy, and neurosurgery in general, over the past century. Early successful operations to treat these tumors were pioneered by prominent figures such as Sir William Macewen and Francesco Durante. Following these early reports, Harvey Cushing made significant contributions, allowing a better understanding and treatment of meningiomas in general, but particularly those involving the anterior cranial base. Initially, large-sized unilateral or bilateral craniotomies were necessary to approach these deep-seated lesions. Technical advances such as the introduction of electrosurgery, the operating microscope, and refined microsurgical instruments allowed neurosurgeons to perform less invasive surgical procedures with better results. Today, a wide variety of surgical strategies, including endoscopic surgery and radiosurgery, are used to treat these tumors. In this review, the authors trace the evolution of craniotomy for anterior cranial fossa meningiomas.
Perioperative allogeneic nonleukoreduced blood transfusion and prostate cancer outcomes after radical prostatectomy
Yeoh, Tze Yeng, Scavonetto, Federica, Karnes, R. Jeffrey , Buskirk, Camille M. van , Hanson, Andrew C. , Schroeder, Darrell R. , Weingarten, Toby N. , Šprung, Juraj , Schroeder, Darrell

Mayo Clinic

Transfusion | March 24, 2014 | Volume: 54 | Issue: 9 | Pages: 2175-2181

10.1111/trf.12595 | PMID 24660833 Get It

BackgroundAllogeneic blood transfusion induces immunosuppression, and concern has been raised that it may increase propensity for cancer recurrence; however, these effects have not been confirmed. We examined the association of perioperative transfusion of allogeneic blood long‐term oncologic outcomes in patients with prostate cancer who underwent prostatectomy.Study Design and MethodsWe reviewed medical records of patients who underwent radical prostatectomy between 1991 and 2005 and received allogeneic nonleukoreduced blood. Each transfused patient was matched to two controls who did not receive blood: matching included age, surgical year, prostate‐specific antigen level, pathologic tumor stages, pathologic Gleason scores, and anesthetic type. Primary outcome was systemic tumor progression, with secondary outcomes of prostate cancer death and all‐cause mortality. Stratified proportional hazards regression analysis was used to assess differences in outcomes between the transfused and nontransfused group.ResultsA total of 379 prostatectomy patients who were transfused and 758 nontransfused controls were followed for 9.4 and 10.2 years (median), respectively. In a multivariable analysis that took into account the matched study design and adjusted for positive surgical margins and adjuvant therapies, the use of allogeneic blood was not associated with systemic tumor progression (hazard ratio [HR], 0.88; 95% confidence interval [CI], 0.39‐1.99; p = 0.76), prostate cancer–specific death (HR, 1.69; 95% CI, 0.44 to 6.48; p = 0.44), or all‐cause death (HR, 1.20; 95% CI, 0.87 to 1.67; p = 0.27).ConclusionsWhen adjusted for clinicopathologic and procedural variables transfusion of allogeneic blood was not associated with systemic tumor progression and survival outcomes.
Anterior inferior petrosectomy: defining the role of endonasal endoscopic techniques for petrous apex approaches
Alikhani, Puya , Tabor, Mark H., Loveren, Harry R. van, Agazzi, Sivero, Froelich, Sébastien , Youssef, A. Samy , Gompel, Jamie J. Van , Tabor, Mark

Mayo Clinic

Journal of Neurosurgery | March 21, 2014 | Volume: 120 | Issue: 6 | Pages: 1321-1325

10.3171/2014.2.jns131773 | PMID 24655102 Get It

Object Historically, surgery to the petrous apex has been addressed via craniotomy and open microscopic anterior petrosectomy (OAP). However, with the popularization of endoscopic approaches, the petrous apex can further be approached endonasally by way of an endoscopic endonasal anterior petrosectomy (EAP). Endonasal anterior petrosectomy is a relatively new procedure and has not been compared anatomically with OAP. The authors hypothesized that the EAP and OAP techniques approach different portions of the petrous apex and therefore may have different applications. Methods Four cadaveric heads were used. An OAP was performed on one side and an EAP was performed on the contralateral side; the limits of bony resection were defined. The extent of bony resection was then evaluated using predissection and postdissection thin-slice CT scans. The comparative resection was then reconstructed using 3D modeling on Brainlab workstations. Results The average resection volumes for EAP and OAP were 0.297 cm 3 and 0.649 cm 3 , respectively, representing a comparative percentage of 46% (EAP/OAP). An EAP and OAP achieved resection of 29% and 64% of the total petrous apex volume, respectively. Indeed, EAP addressed the inferior portion of the petrous apex located adjacent to the petroclival suture more completely than OAP, where 45% of the bone overlying the petroclival suture (petroclival angle to the jugular foramen) was resected with the EAP, while 0% was resected with the OAP. Conclusions In anatomically normal cadavers, OAP achieved nearly a 50% larger volumetric resection than EAP. Furthermore, while OAP appears to completely address the superior portion of the petrous apex, EAP appears to have a niche in approaches to lesions in the inferior petrous apex. Given these results, the authors propose that OAP be redefined as the “superior anterior petrosectomy,” while EAP be referred to as the “inferior anterior petrosectomy,” which more clearly defines the role of each approach in anterior petrosectomy.
Proactive Tobacco Treatment and Population-Level Cessation
Fu, Steven S. , Ryn, Michelle van , Sherman, Scott E. , Noorbaloochi, Siamak , Clothier, Barbara , Taylor, Brent C , Schlede, Carolyn M., Burke, Randy S., Joseph, Anne M. , van Ryn, Michelle, Burgess, Diana Jill , van Ryn, Michelle

Mayo Clinic

JAMA Internal Medicine | March 10, 2014 | Volume: 174 | Issue: 5 | Pages: 671

10.1001/jamainternmed.2014.177 | PMID 24615217 Get It

A Functional N‐terminal Domain in C/EBPβ‐LAP* is Required for Interacting with SWI/SNF and to Repress Ric‐8B Gene Transcription in Osteoblasts
Aguilar, Rodrigo , Grandy, Rodrigo A. , Meza, Daniel, Sepúlveda, Hugo , Pihán, Philippe , Wijnen, André J. van , Lian, Jane B. , Stein, Gary S., Stein, Janet L. , Montecino, Martı́n , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Physiology | February 28, 2014 | Volume: 229 | Issue: 10 | Pages: 1521-1528

10.1002/jcp.24595 | PMID 24585571 Get It

ABSTRACTThe chromatin remodeling complex SWI/SNF and the transcription factor C/EBPβ play critical roles in osteoblastic cells as they jointly control transcription of a number of bone‐related target genes. The largest C/EBPβ isoform, LAP*, possesses a short additional N‐terminal domain that has been proposed to mediate the interaction of this factor with SWI/SNF in myeloid cells. Here we examine the requirement of a functional N‐terminus in C/EBPβ‐LAP* for binding SWI/SNF and for recruiting this complex to the Ric‐8B gene to mediate transcriptional repression. We find that both C/EBPβ‐LAP* and SWI/SNF simultaneously bind to the Ric‐8B promoter in differentiating osteoblasts that repress Ric‐8B expression. This decreased expression of Ric‐8B is not accompanied by significant changes in histone acetylation at the Ric‐8B gene promoter sequence. A single aminoacid change at the C/EBPβ‐LAP* N‐terminus (R3L) that inhibits C/EBPβ‐LAP*‐SWI/SNF interaction, also prevents SWI/SNF recruitment to the Ric‐8B promoter as well as C/EBPβ‐LAP*‐dependent repression of the Ric‐8B gene. Inducible expression of the C/EBPβ‐LAP*R3L protein in stably transfected osteoblastic cells demonstrates that this mutant protein binds to C/EBPβ‐LAP*‐target promoters and competes with the endogenous C/EBPβ factor. Together our results indicate that a functional N‐terminus in C/EBPβ‐LAP* is required for interacting with SWI/SNF and for Ric‐8B gene repression in osteoblasts. J. Cell. Physiol. 229: 1521–1528, 2014. © 2014 Wiley Periodicals, Inc.
Alpha‐synuclein repeat variants and survival in Parkinson's disease
Armasu, Sebastian M. , Anderson, Kari, Frigerio, Roberta , Aasly, Jan , Annesi, Grazia , Bentivoglio, Anna Rita , Brighina, Laura , Chartier‐Harlin, Marie‐Christine , Goldwurm, Stefano , Jasińska‐Myga, Barbara, Jeon, Beom Seok , Kim, Yun Joong , Krüger, Rejko , Lesage, Suzanne , Markopoulou, Katerina , Mellick, George D. , Morrison, Karen , Puschmann, Andreas , Tan, Eng‐King , Crosiers, David , Broeckhoven, Christine Van , Wirdefeldt, Karin , Maraganore, Demetrius M. , Chung, Sun Ju , Biernacka, Joanna M. , Hadjigeorgiou, Georgios M. , Theuns, Jessie , Wszołek, Zbigniew K. , Elbaz, Alexis , Puschmann, Andreas

Mayo Clinic

Movement Disorders | February 27, 2014 | Volume: 29 | Issue: 8 | Pages: 1053-1057

10.1002/mds.25841 | PMID 24578302 Get It

ABSTRACT Objectives To determine whether α‐synuclein dinucleotide repeat (REP1) genotypes are associated with survival in Parkinson's disease (PD). Methods Investigators from the Genetic Epidemiology of Parkinson's Disease Consortium provided REP1 genotypes and baseline and follow‐up clinical data for cases. The primary outcome was time to death. Cox proportional hazards regression models were used to assess the association of REP1 genotypes with survival. Results Twenty‐one sites contributed data for 6,154 cases. There was no significant association between α‐synuclein REP1 genotypes and survival in PD. However, there was a significant association between REP1 genotypes and age at onset of PD (hazard ratio: 1.06; 95% confidence interval: 1.01‐1.10; P value = 0.01). Conclusions In our large consortium study, α‐synuclein REP1 genotypes were not associated with survival in PD. Further studies of α‐synuclein's role in disease progression and long‐term outcomes are needed. © 2014 International Parkinson and Movement Disorder Society
Reduced nocturnal ACTH-driven cortisol secretion during critical illness
Boonen, Eva , Meersseman, Philippe , Vervenne, Hilke, Meyfroidt, Geert , Güiza, Fabián , Wouters, Pieter, Veldhuis, Johannes D. , Berghe, Greet Van den

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | February 26, 2014 | Volume: 306 | Issue: 8 | Pages: E883-E892

10.1152/ajpendo.00009.2014 | PMID 24569590 Get It

Recently, during critical illness, cortisol metabolism was found to be reduced. We hypothesize that such reduced cortisol breakdown may suppress pulsatile ACTH and cortisol secretion via feedback inhibition. To test this hypothesis, nocturnal ACTH and cortisol secretory profiles were constructed by deconvolution analysis from plasma concentration time series in 40 matched critically ill patients and eight healthy controls, excluding diseases or drugs that affect the hypothalamic-pituitary-adrenal axis. Blood was sampled every 10 min between 2100 and 0600 to quantify plasma concentrations of ACTH and (free) cortisol. Approximate entropy, an estimation of process irregularity, cross-approximate entropy, a measure of ACTH-cortisol asynchrony, and ACTH-cortisol dose-response relationships were calculated. Total and free plasma cortisol concentrations were higher at all times in patients than in controls (all P < 0.04). Pulsatile cortisol secretion was 54% lower in patients than in controls ( P = 0.005), explained by reduced cortisol burst mass ( P = 0.03), whereas cortisol pulse frequency ( P = 0.35) and nonpulsatile cortisol secretion ( P = 0.80) were unaltered. Pulsatile ACTH secretion was 31% lower in patients than in controls ( P = 0.03), again explained by a lower ACTH burst mass ( P = 0.02), whereas ACTH pulse frequency ( P = 0.50) and nonpulsatile ACTH secretion ( P = 0.80) were unchanged. ACTH-cortisol dose response estimates were similar in patients and controls. ACTH and cortisol approximate entropy were higher in patients ( P ≤ 0.03), as was ACTH-cortisol cross-approximate entropy ( P ≤ 0.001). We conclude that hypercortisolism during critical illness coincided with suppressed pulsatile ACTH and cortisol secretion and a normal ACTH-cortisol dose response. Increased irregularity and asynchrony of the ACTH and cortisol time series supported non-ACTH-dependent mechanisms driving hypercortisolism during critical illness.
Core Binding Factor β (CBFβ) Is Retained in the Midbody During Cytokinesis
López‐Camacho, César , Wijnen, André J. van , Lian, Jane B. , Stein, Janet L. , Stein, Gary S. , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Physiology | February 24, 2014 | Volume: 229 | Issue: 10 | Pages: 1466-1474

10.1002/jcp.24588 | PMID 24648201 Get It

AbstractCore Binding Factor β (CBFβ) is complexed with the RUNX family of transcription factors in the nucleus to support activation or repression of genes related to bone (RUNX2), hematopoiesis (RUNX1) and gastrointestinal (RUNX3) development. Furthermore, RUNX proteins contribute to the onset and progression of different types of cancer. Although CBFβ localizes to cytoskeletal architecture, its biological role in the cytoplasmic compartment remains to be established. Additionally, the function and localization of CBFβ during the cell cycle are important questions relevant to its biological role. Here we show that CBFβ dynamically distributes in different stages of cell division and importantly is present during telophase at the midbody, a temporal structure important for successful cytokinesis. A functional role for CBFβ localization at the midbody is supported by striking defects in cytokinesis that include polyploidy and abscission failure following siRNA‐mediated downregulation of endogenous CBFβ or overexpression of the inv(16) fusion protein CBFβ‐SMMHC. Our results suggest that CBFβ retention in the midbody during cytokinesis reflects a novel function that contributes to epigenetic control. J. Cell. Physiol. 229: 1466–1474, 2014. © 2014 Wiley Periodicals, Inc.